Immunophenotyping of Chronic Lymphocytic Leukemia

Area of Science:

• Hematology
• Immunophenotyping
• Flow Cytometry

Background:

• Chronic Lymphocytic Leukemia (CLL) is a common diagnosis in flow cytometry.
• Standardized immunophenotyping marker panels for CLL diagnosis are lacking.
• Distinguishing CLL from Mantle Cell Lymphoma (MCL) is crucial for appropriate patient management.

Purpose of the Study:

• To evaluate the diagnostic utility of various flow cytometry markers in differentiating CLL from MCL.
• To determine the significance of specific markers, including CD11c, CD38, and CD43, in CLL immunophenotyping.

Main Methods:

• Retrospective analysis of 339 B lymphoproliferative disorder cases (306 CLL, 33 MCL) using flow cytometry.
• Immunophenotypical analysis focused on the expression of key surface markers.
• Statistical evaluation of marker expression for diagnostic significance.

Main Results:

• CD23 positivity was diagnostic for CLL.
• CD11c, CD38, and CD43 expression demonstrated statistical significance in distinguishing atypical CLL from MCL (p < 0.001).
• CD22, CD79b, and FMC7 expression showed no significant difference between atypical CLL and MCL.

Conclusions:

• CD11c, CD38, and CD43 are more valuable than CD22, CD79b, and FMC7 for diagnosing CLL via flow cytometry.
• These markers, part of the lymphoproliferative disease panel, improve the accuracy of CLL diagnosis.
• The findings support the use of CD11c, CD38, and CD43 in routine flow cytometry for CLL.